Instrument Inactif

Autres langues Proteo, Inc. Other OTC

Actions

PTEO

US74369R3084

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

U.S. Special Forces launch counter-terrorism drills with African armies	01/03/23
PROTEO INC : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	20/07/20
PROTEO INC : Submission of Matters to a Vote of Security Holders (form 8-K)	10/07/20
PROTEO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	05/06/20
Proteo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	05/06/20
PROTEO INC : Other Events (form 8-K)	12/05/20
PROTEO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	07/05/20
Proteo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	07/05/20
PROTEO INC : Other Events (form 8-K)	30/03/20
PROTEO INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	03/03/20
Proteo, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	14/11/19
Proteo, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	05/08/19
Proteo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	14/05/19
Proteo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	15/04/19
Proteo, Inc. Announces Management Changes	19/11/18
Proteo, Inc. and Proteo Biotech AG Announces Final Analysis of the Phase II Clinical Study on Elafin in Coronary Artery Bypass Surgery	21/11/14
Proteo Inc : Patient recruitment and treatment in Elafin CABG Phase II clinical trial completed	08/11/13
Proteo Incorporated : Proteo, Inc. / Proteo Biotech AG: Major advances in the elafin development program for lung diseases – NIH supports research on Elafin with a $10.8 million grant	07/12/11
PROTEO INC : Proteo, Inc. / Proteo Biotech AG: EMPIRE-Study recruits first coronary bypass patients	16/08/11
PROTEO INC : Proteo, Inc./ Proteo Biotech AG: Proteo's Elafin Will Be Tested at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)	18/06/10

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Proteo, Inc. Other OTC

Actions

PTEO

US74369R3084

Autres langues

Filtres